- Home
- OPAD vs NSPR Comparison
OPAD vs NSPR Comparison
Compare OPAD & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- NSPR
- Stock Information
- Founded
- OPAD 2015
- NSPR 2005
- Country
- OPAD United States
- NSPR United States
- Employees
- OPAD N/A
- NSPR N/A
- Industry
- OPAD Real Estate
- NSPR Medical/Dental Instruments
- Sector
- OPAD Finance
- NSPR Health Care
- Exchange
- OPAD Nasdaq
- NSPR Nasdaq
- Market Cap
- OPAD 89.3M
- NSPR 99.7M
- IPO Year
- OPAD N/A
- NSPR N/A
- Fundamental
- Price
- OPAD $2.46
- NSPR $2.27
- Analyst Decision
- OPAD Hold
- NSPR Strong Buy
- Analyst Count
- OPAD 5
- NSPR 2
- Target Price
- OPAD $2.41
- NSPR $4.50
- AVG Volume (30 Days)
- OPAD 3.1M
- NSPR 54.5K
- Earning Date
- OPAD 11-03-2025
- NSPR 11-04-2025
- Dividend Yield
- OPAD N/A
- NSPR N/A
- EPS Growth
- OPAD N/A
- NSPR N/A
- EPS
- OPAD N/A
- NSPR N/A
- Revenue
- OPAD $703,352,000.00
- NSPR $7,066,000.00
- Revenue This Year
- OPAD N/A
- NSPR $7.48
- Revenue Next Year
- OPAD $31.90
- NSPR $104.39
- P/E Ratio
- OPAD N/A
- NSPR N/A
- Revenue Growth
- OPAD N/A
- NSPR 7.60
- 52 Week Low
- OPAD $0.91
- NSPR $1.99
- 52 Week High
- OPAD $6.35
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- OPAD 37.86
- NSPR 31.42
- Support Level
- OPAD $2.80
- NSPR $2.21
- Resistance Level
- OPAD $2.98
- NSPR $2.29
- Average True Range (ATR)
- OPAD 0.26
- NSPR 0.08
- MACD
- OPAD -0.04
- NSPR -0.01
- Stochastic Oscillator
- OPAD 11.90
- NSPR 9.68
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.